Zakrzewski Joseph S
Insider CIK 1331852 · SGMO Director · PODD Director · LPDX Director · XLRN Director · CYT Director · ANTX Director · AMRN Chief Executive Officer, Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| ANTX AN2 Therapeutics, Inc. | G Gift | 2026-08-14 | 2026-08-14 | 405,880 | — | $0 | 0 | SEC↗ |
| ANTX AN2 Therapeutics, Inc. | G Gift | 2026-08-14 | 2026-08-14 | 405,880 | — | $0 | 0 | SEC↗ |
| ANTX AN2 Therapeutics, Inc. | D To issuer deriv | 2026-03-19 | 2026-03-23 | 99,999 | — | $0 | 0 | SEC↗ |
| ANTX AN2 Therapeutics, Inc. | A Award deriv | 2026-03-19 | 2026-03-23 | 10,362 | — | $0 | 10,362 | SEC↗ |
| ANTX AN2 Therapeutics, Inc. | D To issuer deriv | 2026-03-19 | 2026-03-23 | 10,362 | — | $0 | 0 | SEC↗ |
| ANTX AN2 Therapeutics, Inc. | A Award deriv | 2026-03-19 | 2026-03-23 | 23,742 | — | $0 | 23,742 | SEC↗ |
| ANTX AN2 Therapeutics, Inc. | D To issuer deriv | 2026-03-19 | 2026-03-23 | 23,742 | — | $0 | 0 | SEC↗ |
| ANTX AN2 Therapeutics, Inc. | A Award deriv | 2026-03-19 | 2026-03-23 | 99,999 | — | $0 | 99,999 | SEC↗ |
| ANTX AN2 Therapeutics, Inc. | A Award deriv | 2026-02-20 | 2026-02-23 | 20,400 | — | $0 | 20,400 | SEC↗ |
| ANTX AN2 Therapeutics, Inc. | A Award deriv | 2025-05-22 | 2025-05-23 | 19,111 | — | $0 | 19,111 | SEC↗ |
| ANTX AN2 Therapeutics, Inc. | A Award | 2025-04-10 | 2025-04-11 | 10,523 | — | $0 | 145,538 | SEC↗ |
| ANTX AN2 Therapeutics, Inc. | A Award | 2024-12-19 | 2024-12-23 | 9,816 | — | $0 | 135,015 | SEC↗ |
| ANTX AN2 Therapeutics, Inc. | P Buy | 2024-11-27 | 2024-11-27 | 2,000 | $1.40 | $2.8K | 125,199 | SEC↗ |
| ANTX AN2 Therapeutics, Inc. | P Buy | 2024-11-19 | 2024-11-20 | 5,000 | $1.01 | $5.0K | 123,199 | SEC↗ |
| ANTX AN2 Therapeutics, Inc. | P Buy | 2024-11-18 | 2024-11-20 | 20,000 | $1.00 | $20.0K | 118,199 | SEC↗ |
| ANTX AN2 Therapeutics, Inc. | A Award deriv | 2024-06-19 | 2024-06-21 | 64,503 | — | $0 | 64,503 | SEC↗ |
| CYT Cyteir Therapeutics, Inc. | M Exercise deriv | 2024-02-06 | 2024-02-08 | 14,150 | — | $0 | 0 | SEC↗ |
| CYT Cyteir Therapeutics, Inc. | M Exercise | 2024-02-06 | 2024-02-08 | 14,150 | $1.69 | $23.9K | 227,439 | SEC↗ |
| ANTX AN2 Therapeutics, Inc. | S Sale | 2024-01-18 | 2024-01-19 | 100,000 | $19.11 | $1.91M | 405,880 | SEC↗ |
| ANTX AN2 Therapeutics, Inc. | A Award deriv | 2023-06-07 | 2023-06-09 | 23,742 | — | $0 | 23,742 | SEC↗ |
| CYT Cyteir Therapeutics, Inc. | A Award deriv | 2023-02-03 | 2023-02-07 | 14,150 | — | $0 | 14,150 | SEC↗ |
| CYT Cyteir Therapeutics, Inc. | P Buy | 2022-12-07 | 2022-12-08 | 21,202 | $1.30 | $27.6K | 154,618 | SEC↗ |
| ANTX AN2 Therapeutics, Inc. | A Award deriv | 2022-05-12 | 2022-05-16 | 10,362 | — | $0 | 10,362 | SEC↗ |
| CYT Cyteir Therapeutics, Inc. | P Buy | 2022-05-12 | 2022-05-16 | 743 | $1.61 | $1.2K | 133,416 | SEC↗ |
| CYT Cyteir Therapeutics, Inc. | P Buy | 2022-05-11 | 2022-05-12 | 1,000 | $1.70 | $1.7K | 132,673 | SEC↗ |
| CYT Cyteir Therapeutics, Inc. | P Buy | 2022-05-10 | 2022-05-12 | 49,406 | $1.89 | $93.4K | 131,673 | SEC↗ |
| ANTX AN2 Therapeutics, Inc. | C Conversion deriv | 2022-03-29 | 2022-03-31 | 98,199 | — | $0 | 0 | SEC↗ |
| ANTX AN2 Therapeutics, Inc. | C Conversion | 2022-03-29 | 2022-03-31 | 98,199 | — | $0 | 98,199 | SEC↗ |
| SGMO SANGAMO THERAPEUTICS, INC | A Award deriv | 2022-02-25 | 2022-03-01 | 25,000 | — | $0 | 25,000 | SEC↗ |
| SGMO SANGAMO THERAPEUTICS, INC | A Award | 2022-02-25 | 2022-03-01 | 12,500 | — | $0 | 60,700 | SEC↗ |
| CYT Cyteir Therapeutics, Inc. | A Award deriv | 2022-02-22 | 2022-02-24 | 14,150 | — | $0 | 14,150 | SEC↗ |
| CYT Cyteir Therapeutics, Inc. | P Buy | 2021-12-28 | 2021-12-28 | 601 | $9.85 | $5.9K | 82,267 | SEC↗ |
| CYT Cyteir Therapeutics, Inc. | P Buy | 2021-12-27 | 2021-12-28 | 99 | $10.18 | $1.0K | 81,666 | SEC↗ |
| CYT Cyteir Therapeutics, Inc. | P Buy | 2021-12-27 | 2021-12-28 | 200 | $9.97 | $2.0K | 81,567 | SEC↗ |
| CYT Cyteir Therapeutics, Inc. | P Buy | 2021-12-23 | 2021-12-28 | 200 | $9.87 | $2.0K | 81,367 | SEC↗ |
| CYT Cyteir Therapeutics, Inc. | P Buy | 2021-12-17 | 2021-12-21 | 200 | $9.88 | $2.0K | 81,167 | SEC↗ |
| CYT Cyteir Therapeutics, Inc. | P Buy | 2021-12-15 | 2021-12-15 | 2,000 | $10.47 | $20.9K | 79,267 | SEC↗ |
| CYT Cyteir Therapeutics, Inc. | P Buy | 2021-12-15 | 2021-12-15 | 1,700 | $11.12 | $18.9K | 80,967 | SEC↗ |
| AMRN AMARIN CORP PLC\UK | P Buy | 2021-12-15 | 2021-12-16 | 2,000 | $3.16 | $6.3K | 196,547 | SEC↗ |
| AMRN AMARIN CORP PLC\UK | P Buy | 2021-12-14 | 2021-12-16 | 10,000 | $3.27 | $32.7K | 194,547 | SEC↗ |
| XLRN ACCELERON PHARMA INC | D To issuer deriv | 2021-11-19 | 2021-11-22 | 10,000 | — | $0 | 0 | SEC↗ |
| XLRN ACCELERON PHARMA INC | D To issuer deriv | 2021-11-19 | 2021-11-22 | 7,500 | — | $0 | 0 | SEC↗ |
| XLRN ACCELERON PHARMA INC | D To issuer deriv | 2021-11-19 | 2021-11-22 | 10,000 | — | $0 | 0 | SEC↗ |
| XLRN ACCELERON PHARMA INC | D To issuer deriv | 2021-11-19 | 2021-11-22 | 7,500 | — | $0 | 0 | SEC↗ |
| XLRN ACCELERON PHARMA INC | D To issuer deriv | 2021-11-19 | 2021-11-22 | 7,500 | — | $0 | 0 | SEC↗ |
| XLRN ACCELERON PHARMA INC | D To issuer deriv | 2021-11-19 | 2021-11-22 | 8,185 | — | $0 | 0 | SEC↗ |
| XLRN ACCELERON PHARMA INC | D To issuer deriv | 2021-11-19 | 2021-11-22 | 3,222 | — | $0 | 0 | SEC↗ |
| XLRN ACCELERON PHARMA INC | U Tender | 2021-11-19 | 2021-11-22 | 34,499 | — | $0 | 0 | SEC↗ |
| CYT Cyteir Therapeutics, Inc. | C Conversion deriv | 2021-06-22 | 2021-06-24 | 200,000 | — | $0 | 0 | SEC↗ |
| CYT Cyteir Therapeutics, Inc. | C Conversion | 2021-06-22 | 2021-06-24 | 58,671 | — | $0 | 58,671 | SEC↗ |
| AMRN AMARIN CORP PLC\UK | A Award deriv | 2021-06-14 | 2021-06-16 | 45,953 | — | $0 | 45,953 | SEC↗ |
| AMRN AMARIN CORP PLC\UK | A Award deriv | 2021-06-14 | 2021-06-16 | 36,000 | — | $0 | 36,000 | SEC↗ |
| XLRN ACCELERON PHARMA INC | M Exercise deriv | 2021-04-05 | 2021-04-05 | 10,000 | — | $0 | 0 | SEC↗ |
| XLRN ACCELERON PHARMA INC | S Sale | 2021-04-05 | 2021-04-05 | 6,748 | $140.31 | $946.8K | 37,751 | SEC↗ |
| XLRN ACCELERON PHARMA INC | M Exercise | 2021-04-05 | 2021-04-05 | 10,000 | $24.11 | $241.1K | 44,499 | SEC↗ |
| XLRN ACCELERON PHARMA INC | S Sale | 2021-04-05 | 2021-04-05 | 1,100 | $142.27 | $156.5K | 34,499 | SEC↗ |
| XLRN ACCELERON PHARMA INC | S Sale | 2021-04-05 | 2021-04-05 | 2,152 | $141.28 | $304.0K | 35,599 | SEC↗ |
| XLRN ACCELERON PHARMA INC | M Exercise deriv | 2021-04-01 | 2021-04-02 | 10,000 | — | $0 | 10,000 | SEC↗ |
| XLRN ACCELERON PHARMA INC | S Sale | 2021-04-01 | 2021-04-02 | 1,700 | $135.22 | $229.9K | 36,099 | SEC↗ |
| XLRN ACCELERON PHARMA INC | S Sale | 2021-04-01 | 2021-04-02 | 6,596 | $134.27 | $885.6K | 37,799 | SEC↗ |
| XLRN ACCELERON PHARMA INC | S Sale | 2021-04-01 | 2021-04-02 | 1,600 | $135.67 | $217.1K | 34,499 | SEC↗ |
| XLRN ACCELERON PHARMA INC | M Exercise | 2021-04-01 | 2021-04-02 | 10,000 | $24.11 | $241.1K | 44,499 | SEC↗ |
| XLRN ACCELERON PHARMA INC | S Sale | 2021-04-01 | 2021-04-02 | 104 | $132.61 | $13.8K | 44,395 | SEC↗ |
| SGMO SANGAMO THERAPEUTICS, INC | A Award deriv | 2021-02-25 | 2021-03-01 | 16,400 | — | $0 | 16,400 | SEC↗ |
| SGMO SANGAMO THERAPEUTICS, INC | A Award | 2021-02-25 | 2021-03-01 | 8,200 | — | $0 | 48,200 | SEC↗ |
| XLRN ACCELERON PHARMA INC | A Award deriv | 2021-01-29 | 2021-02-02 | 3,222 | — | $0 | 3,222 | SEC↗ |
| XLRN ACCELERON PHARMA INC | A Award | 2021-01-29 | 2021-02-02 | 1,622 | — | $0 | 34,499 | SEC↗ |
| AMRN AMARIN CORP PLC\UK | M Exercise deriv | 2020-10-21 | 2020-10-22 | 100,000 | — | $0 | 0 | SEC↗ |
| AMRN AMARIN CORP PLC\UK | M Exercise | 2020-10-21 | 2020-10-22 | 100,000 | $3.40 | $340.0K | 184,547 | SEC↗ |
| AMRN AMARIN CORP PLC\UK | A Award deriv | 2020-07-13 | 2020-07-15 | 27,191 | — | $0 | 27,191 | SEC↗ |
| AMRN AMARIN CORP PLC\UK | A Award deriv | 2020-07-13 | 2020-07-15 | 34,805 | — | $0 | 34,805 | SEC↗ |
| SGMO SANGAMO THERAPEUTICS, INC | A Award deriv | 2020-05-18 | 2020-05-20 | 15,000 | — | $0 | 15,000 | SEC↗ |
| SGMO SANGAMO THERAPEUTICS, INC | A Award deriv | 2020-05-18 | 2020-06-03 | 20,000 | — | $0 | 20,000 | SEC↗ |
| SGMO SANGAMO THERAPEUTICS, INC | A Award | 2020-05-18 | 2020-05-20 | 2,500 | — | $0 | 32,500 | SEC↗ |
| SGMO SANGAMO THERAPEUTICS, INC | A Award | 2020-05-18 | 2020-06-03 | 10,000 | — | $0 | 40,000 | SEC↗ |
| SGMO SANGAMO THERAPEUTICS, INC | P Buy | 2020-03-17 | 2020-03-19 | 5,000 | $4.99 | $24.9K | 30,000 | SEC↗ |
| SGMO SANGAMO THERAPEUTICS, INC | P Buy | 2020-03-13 | 2020-03-13 | 5,000 | $5.67 | $28.4K | 25,000 | SEC↗ |
| SGMO SANGAMO THERAPEUTICS, INC | P Buy | 2020-03-12 | 2020-03-13 | 15,000 | $6.31 | $94.7K | 20,000 | SEC↗ |
| XLRN ACCELERON PHARMA INC | A Award deriv | 2020-01-22 | 2020-01-24 | 8,185 | — | $0 | 8,185 | SEC↗ |
| XLRN ACCELERON PHARMA INC | A Award | 2020-01-22 | 2020-01-24 | 1,377 | — | $0 | 32,877 | SEC↗ |
| XLRN ACCELERON PHARMA INC | M Exercise deriv | 2020-01-07 | 2020-01-09 | 18,750 | — | $0 | 0 | SEC↗ |
| XLRN ACCELERON PHARMA INC | M Exercise | 2020-01-07 | 2020-01-09 | 18,750 | $3.88 | $72.8K | 31,500 | SEC↗ |
| AMRN AMARIN CORP PLC\UK | M Exercise deriv | 2020-01-03 | 2020-01-03 | 300,000 | — | $0 | 100,000 | SEC↗ |
| AMRN AMARIN CORP PLC\UK | S Sale | 2020-01-03 | 2020-01-03 | 300,000 | $20.94 | $6.28M | 84,547 | SEC↗ |
| AMRN AMARIN CORP PLC\UK | M Exercise | 2020-01-03 | 2020-01-03 | 300,000 | $3.40 | $1.02M | 384,547 | SEC↗ |
| AMRN AMARIN CORP PLC\UK | M Exercise deriv | 2019-12-16 | 2019-12-18 | 100,000 | — | $0 | 138,542 | SEC↗ |
| AMRN AMARIN CORP PLC\UK | M Exercise | 2019-12-16 | 2019-12-18 | 100,000 | $9.00 | $900.0K | 184,547 | SEC↗ |
| AMRN AMARIN CORP PLC\UK | S Sale | 2019-12-16 | 2019-12-18 | 100,000 | $25.83 | $2.58M | 84,547 | SEC↗ |
| AMRN AMARIN CORP PLC\UK | M Exercise deriv | 2019-07-05 | 2019-07-05 | 100,000 | — | $0 | 238,542 | SEC↗ |
| AMRN AMARIN CORP PLC\UK | S Sale | 2019-07-05 | 2019-07-05 | 100,000 | $23.82 | $2.38M | 84,547 | SEC↗ |
| AMRN AMARIN CORP PLC\UK | M Exercise | 2019-07-05 | 2019-07-05 | 100,000 | $9.00 | $900.0K | 184,547 | SEC↗ |
| AMRN AMARIN CORP PLC\UK | M Exercise deriv | 2019-06-18 | 2019-06-20 | 100,000 | — | $0 | 400,000 | SEC↗ |
| AMRN AMARIN CORP PLC\UK | M Exercise | 2019-06-18 | 2019-06-20 | 100,000 | $3.40 | $340.0K | 184,547 | SEC↗ |
| AMRN AMARIN CORP PLC\UK | S Sale | 2019-06-18 | 2019-06-20 | 100,000 | $19.02 | $1.90M | 84,547 | SEC↗ |
| XLRN ACCELERON PHARMA INC | P Buy | 2019-06-14 | 2019-06-17 | 5,000 | $38.05 | $190.3K | 12,750 | SEC↗ |
| SGMO SANGAMO THERAPEUTICS, INC | A Award deriv | 2019-06-10 | 2019-06-12 | 15,000 | — | $0 | 15,000 | SEC↗ |
| SGMO SANGAMO THERAPEUTICS, INC | A Award | 2019-06-10 | 2019-06-12 | 2,500 | — | $0 | 5,000 | SEC↗ |
| AMRN AMARIN CORP PLC\UK | A Award deriv | 2019-05-20 | 2019-05-21 | 7,428 | — | $0 | 7,428 | SEC↗ |
| AMRN AMARIN CORP PLC\UK | A Award deriv | 2019-05-20 | 2019-05-21 | 9,658 | — | $0 | 9,658 | SEC↗ |
| AMRN AMARIN CORP PLC\UK | M Exercise deriv | 2019-02-22 | 2019-02-22 | 143,750 | — | $0 | 0 | SEC↗ |
| AMRN AMARIN CORP PLC\UK | M Exercise deriv | 2019-02-22 | 2019-02-22 | 36,875 | — | $0 | 0 | SEC↗ |
| AMRN AMARIN CORP PLC\UK | M Exercise | 2019-02-22 | 2019-02-22 | 36,875 | $8.10 | $298.7K | 265,172 | SEC↗ |
| AMRN AMARIN CORP PLC\UK | M Exercise | 2019-02-22 | 2019-02-22 | 143,750 | $8.86 | $1.27M | 228,297 | SEC↗ |
| AMRN AMARIN CORP PLC\UK | S Sale | 2019-02-22 | 2019-02-22 | 180,625 | $19.90 | $3.59M | 84,547 | SEC↗ |
| XLRN ACCELERON PHARMA INC | A Award deriv | 2019-01-25 | 2019-01-29 | 7,500 | — | $0 | 7,500 | SEC↗ |
| XLRN ACCELERON PHARMA INC | A Award | 2019-01-25 | 2019-01-29 | 1,250 | — | $0 | 7,750 | SEC↗ |
| AMRN AMARIN CORP PLC\UK | M Exercise deriv | 2019-01-10 | 2019-01-11 | 200,000 | — | $0 | 500,000 | SEC↗ |
| AMRN AMARIN CORP PLC\UK | M Exercise | 2019-01-10 | 2019-01-11 | 200,000 | $3.40 | $680.0K | 284,547 | SEC↗ |
| AMRN AMARIN CORP PLC\UK | S Sale | 2019-01-10 | 2019-01-11 | 100,000 | $16.00 | $1.60M | 184,547 | SEC↗ |
| AMRN AMARIN CORP PLC\UK | S Sale | 2019-01-10 | 2019-01-11 | 100,000 | $17.96 | $1.80M | 84,547 | SEC↗ |
| AMRN AMARIN CORP PLC\UK | M Exercise deriv | 2019-01-02 | 2019-01-02 | 350,000 | — | $0 | 700,000 | SEC↗ |
| AMRN AMARIN CORP PLC\UK | M Exercise deriv | 2019-01-02 | 2019-01-02 | 35,000 | — | $0 | 0 | SEC↗ |
| AMRN AMARIN CORP PLC\UK | S Sale | 2019-01-02 | 2019-01-02 | 385,000 | $13.03 | $5.02M | 84,547 | SEC↗ |
| AMRN AMARIN CORP PLC\UK | M Exercise | 2019-01-02 | 2019-01-02 | 350,000 | $3.40 | $1.19M | 434,547 | SEC↗ |
| AMRN AMARIN CORP PLC\UK | M Exercise | 2019-01-02 | 2019-01-02 | 35,000 | $1.35 | $47.3K | 469,547 | SEC↗ |
| AMRN AMARIN CORP PLC\UK | S Sale | 2018-12-28 | 2019-01-02 | 141,500 | $13.19 | $1.87M | 84,547 | SEC↗ |
| AMRN AMARIN CORP PLC\UK | M Exercise deriv | 2018-09-24 | 2018-09-26 | 500,000 | — | $0 | 1,050,000 | SEC↗ |
| AMRN AMARIN CORP PLC\UK | S Sale | 2018-09-24 | 2018-09-26 | 65,800 | $12.18 | $801.4K | 226,047 | SEC↗ |
| AMRN AMARIN CORP PLC\UK | M Exercise | 2018-09-24 | 2018-09-26 | 500,000 | $3.40 | $1.70M | 726,047 | SEC↗ |
| AMRN AMARIN CORP PLC\UK | S Sale | 2018-09-24 | 2018-09-26 | 407,251 | $10.30 | $4.19M | 318,796 | SEC↗ |
| AMRN AMARIN CORP PLC\UK | S Sale | 2018-09-24 | 2018-09-26 | 26,949 | $11.23 | $302.6K | 291,847 | SEC↗ |
| SGMO SANGAMO THERAPEUTICS, INC | A Award deriv | 2018-06-11 | 2018-06-12 | 15,000 | — | $0 | 15,000 | SEC↗ |
| SGMO SANGAMO THERAPEUTICS, INC | A Award | 2018-06-11 | 2018-06-12 | 2,500 | — | $0 | 2,500 | SEC↗ |
| AMRN AMARIN CORP PLC\UK | A Award deriv | 2018-05-14 | 2018-10-02 | 46,973 | — | $0 | 46,973 | SEC↗ |
| AMRN AMARIN CORP PLC\UK | A Award deriv | 2018-05-14 | 2018-10-02 | 31,153 | — | $0 | 31,153 | SEC↗ |
| XLRN ACCELERON PHARMA INC | A Award deriv | 2018-03-01 | 2018-03-05 | 7,500 | — | $0 | 7,500 | SEC↗ |
| XLRN ACCELERON PHARMA INC | A Award | 2018-03-01 | 2018-03-05 | 1,250 | — | $0 | 6,500 | SEC↗ |
| SGMO SANGAMO THERAPEUTICS, INC | A Award deriv | 2017-06-27 | 2017-06-29 | 30,000 | — | $0 | 30,000 | SEC↗ |
| PODD INSULET CORP | A Award deriv | 2017-05-17 | 2017-05-18 | 3,587 | — | $0 | 3,587 | SEC↗ |
| PODD INSULET CORP | A Award | 2017-05-17 | 2017-05-18 | 2,709 | — | $0 | 30,558 | SEC↗ |
| AMRN AMARIN CORP PLC\UK | A Award deriv | 2017-05-15 | 2017-05-17 | 21,146 | — | $0 | 21,146 | SEC↗ |
| AMRN AMARIN CORP PLC\UK | A Award deriv | 2017-05-15 | 2017-05-17 | 14,706 | — | $0 | 14,706 | SEC↗ |
| PODD INSULET CORP | M Exercise deriv | 2017-03-02 | 2017-03-03 | 4,000 | — | $0 | 0 | SEC↗ |
| PODD INSULET CORP | M Exercise deriv | 2017-03-02 | 2017-03-03 | 4,000 | — | $0 | 0 | SEC↗ |
| PODD INSULET CORP | M Exercise deriv | 2017-03-02 | 2017-03-03 | 4,000 | — | $0 | 0 | SEC↗ |
| PODD INSULET CORP | M Exercise deriv | 2017-03-02 | 2017-03-03 | 18,480 | — | $0 | 0 | SEC↗ |
| PODD INSULET CORP | M Exercise deriv | 2017-03-02 | 2017-03-03 | 9,520 | — | $0 | 0 | SEC↗ |
| XLRN ACCELERON PHARMA INC | A Award deriv | 2017-03-02 | 2017-03-14 | 7,500 | — | $0 | 7,500 | SEC↗ |
| PODD INSULET CORP | M Exercise | 2017-03-02 | 2017-03-03 | 4,000 | $14.48 | $57.9K | 59,849 | SEC↗ |
| PODD INSULET CORP | M Exercise | 2017-03-02 | 2017-03-03 | 9,520 | $18.75 | $178.5K | 37,369 | SEC↗ |
| PODD INSULET CORP | M Exercise | 2017-03-02 | 2017-03-03 | 18,480 | $7.06 | $130.5K | 55,849 | SEC↗ |
| PODD INSULET CORP | M Exercise | 2017-03-02 | 2017-03-03 | 4,000 | $20.90 | $83.6K | 63,849 | SEC↗ |
| PODD INSULET CORP | M Exercise | 2017-03-02 | 2017-03-03 | 4,000 | $17.75 | $71.0K | 67,849 | SEC↗ |
| PODD INSULET CORP | S Sale | 2017-03-02 | 2017-03-03 | 4,000 | $48.03 | $192.1K | 63,849 | SEC↗ |
| PODD INSULET CORP | S Sale | 2017-03-02 | 2017-03-03 | 13,721 | $46.31 | $635.4K | 50,128 | SEC↗ |
| PODD INSULET CORP | S Sale | 2017-03-02 | 2017-03-03 | 22,279 | $46.99 | $1.05M | 27,849 | SEC↗ |
| XLRN ACCELERON PHARMA INC | A Award | 2017-03-02 | 2017-03-14 | 1,250 | — | $0 | 5,250 | SEC↗ |
| XLRN ACCELERON PHARMA INC | P Buy | 2016-12-30 | 2017-01-03 | 4,000 | $25.50 | $102.0K | 4,000 | SEC↗ |
| AMRN AMARIN CORP PLC\UK | A Award deriv | 2016-07-11 | 2016-07-13 | 20,548 | — | $0 | 20,548 | SEC↗ |
| AMRN AMARIN CORP PLC\UK | A Award deriv | 2016-07-11 | 2016-07-13 | 28,847 | — | $0 | 28,847 | SEC↗ |
| PODD INSULET CORP | A Award deriv | 2016-05-11 | 2016-05-13 | 5,235 | — | $0 | 5,235 | SEC↗ |
| PODD INSULET CORP | A Award | 2016-05-11 | 2016-05-13 | 3,810 | — | $0 | 27,849 | SEC↗ |
| XLRN ACCELERON PHARMA INC | A Award deriv | 2016-03-03 | 2016-03-07 | 10,000 | — | $0 | 10,000 | SEC↗ |
| AMRN AMARIN CORP PLC\UK | A Award deriv | 2015-07-06 | 2015-07-08 | 23,144 | — | $0 | 23,144 | SEC↗ |
| AMRN AMARIN CORP PLC\UK | A Award deriv | 2015-07-06 | 2015-07-08 | 17,358 | — | $0 | 17,358 | SEC↗ |
| AMRN AMARIN CORP PLC\UK | A Award deriv | 2015-07-06 | 2015-07-08 | 40,500 | — | $0 | 40,500 | SEC↗ |
| AMRN AMARIN CORP PLC\UK | A Award deriv | 2015-07-06 | 2015-07-08 | 18,000 | — | $0 | 18,000 | SEC↗ |
| PODD INSULET CORP | A Award deriv | 2015-05-13 | 2015-05-18 | 5,525 | — | $0 | 5,525 | SEC↗ |
| PODD INSULET CORP | A Award | 2015-05-13 | 2015-05-18 | 4,039 | — | $0 | 24,039 | SEC↗ |
| XLRN ACCELERON PHARMA INC | A Award deriv | 2015-01-08 | 2015-04-08 | 10,000 | — | $0 | 10,000 | SEC↗ |
| XLRN ACCELERON PHARMA INC | A Award deriv | 2015-01-08 | 2015-01-09 | 10,000 | — | $0 | 10,000 | SEC↗ |
| LPDX LIPOSCIENCE INC | D To issuer | 2014-11-20 | 2014-11-24 | 25,372 | $5.25 | $133.2K | 0 | SEC↗ |
| LPDX LIPOSCIENCE INC | A Award | 2014-06-11 | 2014-06-13 | 8,955 | — | $0 | 25,372 | SEC↗ |
| LPDX LIPOSCIENCE INC | A Award | 2014-06-11 | 2014-06-13 | 16,417 | — | $0 | 16,417 | SEC↗ |
| PODD INSULET CORP | A Award deriv | 2014-06-02 | 2014-06-13 | 4,000 | — | $0 | 4,000 | SEC↗ |
| PODD INSULET CORP | A Award | 2014-06-02 | 2014-06-13 | 4,000 | — | $0 | 20,000 | SEC↗ |
| AMRN AMARIN CORP PLC\UK | A Award deriv | 2014-03-11 | 2014-03-13 | 24,000 | — | $0 | 24,000 | SEC↗ |
| AMRN AMARIN CORP PLC\UK | A Award deriv | 2014-03-11 | 2014-03-13 | 28,500 | — | $0 | 28,500 | SEC↗ |
| XLRN ACCELERON PHARMA INC | A Award deriv | 2013-12-05 | 2013-12-09 | 20,000 | — | $0 | 20,000 | SEC↗ |
| AMRN AMARIN CORP PLC\UK | P Buy | 2013-11-18 | 2013-11-18 | 50,777 | $1.54 | $78.2K | 226,047 | SEC↗ |
| AMRN AMARIN CORP PLC\UK | M Exercise deriv | 2013-07-26 | 2013-07-26 | 33,333 | — | $0 | 0 | SEC↗ |
| AMRN AMARIN CORP PLC\UK | M Exercise | 2013-07-26 | 2013-07-26 | 33,333 | — | $0 | 175,270 | SEC↗ |
| AMRN AMARIN CORP PLC\UK | M Exercise deriv | 2013-06-25 | 2013-06-25 | 10,000 | — | $0 | 35,000 | SEC↗ |
| AMRN AMARIN CORP PLC\UK | M Exercise | 2013-06-25 | 2013-06-25 | 10,000 | $1.35 | $13.5K | 141,937 | SEC↗ |
| AMRN AMARIN CORP PLC\UK | M Exercise deriv | 2013-06-21 | 2013-06-21 | 10,000 | — | $0 | 45,000 | SEC↗ |
| AMRN AMARIN CORP PLC\UK | M Exercise | 2013-06-21 | 2013-06-21 | 10,000 | $1.35 | $13.5K | 131,937 | SEC↗ |
| PODD INSULET CORP | A Award deriv | 2013-06-03 | 2013-06-05 | 4,000 | — | $0 | 4,000 | SEC↗ |
| PODD INSULET CORP | A Award | 2013-06-03 | 2013-06-05 | 4,000 | — | $0 | 16,000 | SEC↗ |
| AMRN AMARIN CORP PLC\UK | M Exercise deriv | 2013-04-25 | 2013-04-25 | 10,000 | — | $0 | 55,000 | SEC↗ |
| AMRN AMARIN CORP PLC\UK | M Exercise | 2013-04-25 | 2013-04-25 | 10,000 | $1.35 | $13.5K | 121,937 | SEC↗ |
| AMRN AMARIN CORP PLC\UK | A Award deriv | 2013-01-02 | 2013-01-02 | 147,500 | — | $0 | 147,500 | SEC↗ |
| AMRN AMARIN CORP PLC\UK | M Exercise deriv | 2012-10-01 | 2012-10-03 | 150,000 | — | $0 | 65,000 | SEC↗ |
| AMRN AMARIN CORP PLC\UK | M Exercise | 2012-10-01 | 2012-10-03 | 150,000 | $1.35 | $202.5K | 261,937 | SEC↗ |
| AMRN AMARIN CORP PLC\UK | S Sale | 2012-10-01 | 2012-10-03 | 150,000 | $12.56 | $1.88M | 111,937 | SEC↗ |
| AMRN AMARIN CORP PLC\UK | M Exercise deriv | 2012-07-27 | 2012-07-30 | 150,000 | — | $0 | 215,000 | SEC↗ |
| AMRN AMARIN CORP PLC\UK | S Sale | 2012-07-27 | 2012-07-30 | 78,054 | $14.07 | $1.10M | 111,937 | SEC↗ |
| AMRN AMARIN CORP PLC\UK | M Exercise | 2012-07-27 | 2012-07-30 | 150,000 | $1.35 | $202.5K | 261,937 | SEC↗ |
| AMRN AMARIN CORP PLC\UK | S Sale | 2012-07-27 | 2012-07-30 | 71,946 | $14.58 | $1.05M | 189,991 | SEC↗ |
| AMRN AMARIN CORP PLC\UK | A Award deriv | 2012-07-26 | 2012-07-30 | 33,333 | — | $0 | 33,333 | SEC↗ |
| AMRN AMARIN CORP PLC\UK | A Award | 2012-07-26 | 2012-07-30 | 33,333 | — | $0 | 111,937 | SEC↗ |
| PODD INSULET CORP | A Award deriv | 2012-06-01 | 2012-06-05 | 4,000 | — | $0 | 4,000 | SEC↗ |
| PODD INSULET CORP | A Award | 2012-06-01 | 2012-06-05 | 4,000 | — | $0 | 12,000 | SEC↗ |
| AMRN AMARIN CORP PLC\UK | M Exercise deriv | 2012-05-29 | 2012-05-31 | 150,000 | — | $0 | 365,000 | SEC↗ |
| AMRN AMARIN CORP PLC\UK | S Sale | 2012-05-29 | 2012-05-31 | 150,000 | $11.97 | $1.80M | 78,604 | SEC↗ |
| AMRN AMARIN CORP PLC\UK | M Exercise | 2012-05-29 | 2012-05-31 | 150,000 | $1.35 | $202.5K | 228,604 | SEC↗ |
| AMRN AMARIN CORP PLC\UK | M Exercise deriv | 2012-03-23 | 2012-03-27 | 160,000 | — | $0 | 515,000 | SEC↗ |
| AMRN AMARIN CORP PLC\UK | M Exercise | 2012-03-23 | 2012-03-27 | 160,000 | $1.35 | $216.0K | 238,604 | SEC↗ |
| AMRN AMARIN CORP PLC\UK | S Sale | 2012-03-23 | 2012-03-27 | 160,000 | $11.59 | $1.85M | 78,604 | SEC↗ |
| PODD INSULET CORP | S Sale | 2012-02-17 | 2012-02-21 | 3,000 | $20.20 | $60.6K | 8,000 | SEC↗ |
| PODD INSULET CORP | S Sale | 2012-02-16 | 2012-02-21 | 2,000 | $20.67 | $41.3K | 11,000 | SEC↗ |
| AMRN AMARIN CORP PLC\UK | A Award deriv | 2012-02-01 | 2012-02-03 | 300,000 | — | $0 | 300,000 | SEC↗ |